Related Experiment Videos
[Extrapulmonary small-cell carcinoma - a rarity with important therapeutic consequences]
Schweizerische Medizinische Wochenschrift
|February 4, 1984
Summary
Extrapulmonary small cell carcinoma (ESCC) shares similarities with lung cancer. Systemic therapy is crucial for managing ESCC, as local treatments often lead to distant metastases.
Area of Science:
- Oncology
- Medical Research
Context:
- Extrapulmonary small cell carcinoma (ESCC) is a rare malignancy.
- Limited data exists on its clinical course and treatment outcomes.
Purpose:
- To report on the clinical characteristics, treatment, and outcomes of 12 patients with ESCC.
- To compare the behavior of ESCC to pulmonary small cell carcinoma.
Summary:
- Twelve patients with ESCC were analyzed, with primary tumors identified in the cervix, esophagus, prostate, and pancreas.
- Distant metastases, including CNS involvement, were common at diagnosis or developed later.
- While initial local treatments (surgery, radiotherapy) were associated with metastasis, chemotherapy showed promising response rates.
- Three patients achieved long-term survival (18+, 80+, 81+ months) without evidence of disease.
Impact:
- ESCC biology and clinical course resemble pulmonary small cell carcinoma.
- Highlights the importance of systemic treatment in managing ESCC.
- Suggests that aggressive systemic therapy should be prioritized for patients with ESCC.